aneurysm (AAA) diameter, aortic neck, and iliac arteries in patients undergoing endovascular aneurysm repair (EVAR) and to evaluate the impact of these variables on survival after EVAR.
treated by EVAR was 49% compared with 73% in men. In multivariate analysis, sex was not statistically significant. Increase in age, iliac artery length, congestive heart failure, dialysis, and BMI <25 kg/m 2 or >30 kg/ m 2 were significantly associated with shorter survival (Table 2) . Conclusions: Significant anatomic differences exist between men and women undergoing EVAR. Women present at an older age but with similar AAA diameter to that of men. Women have more hostile anatomy in general and have a significantly reduced survival than men after EVAR. After controlling for comorbidities, aortic neck, and iliac artery anatomy, gender does not appear to be an independent predictor for survival.
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Anemia and Postoperative Outcomes After Elective Abdominal Aneurysm Repair
Hanaa Dakour Aridi, Besma Nejim, Nawar Paracha, Widian Alshwaily, Satinderjt Locham, Mahmoud Malas. Johns Hopkins University, Baltimore, Md
Background: Anemia is associated with increased cardiac adverse events during the early postoperative period because of high physiologic stress and increased cardiac demand. The aim of this study was to assess the surgical outcomes and prognostic implications of anemia in abdominal aortic aneurysm (AAA) patients.
Methods: A retrospective analysis of all patients who underwent open aortic repair (OAR) or endovascular aneurysm repair (EVAR) in the Vascular Quality Initiative database (2008-2017) was performed. We excluded patients with preoperative polycythemia, patients with ruptured aneurysms, and patients transfused with >4 units of packed red blood cells to avoid inclusion of patients with blood loss anemia. The primary outcome was in-hospital major adverse cardiac events (MACEs), defined as the occurrence of myocardial infarction, stroke, or death. Based on the location of knots (significant change in slopes) in the cubic spline model, hemoglobin levels were categorized into three groups: severe anemia (<10 g/dL), mild anemia (10-12 g/dL in women and 10-13 g/dL in men), and no anemia (>12 g/dL and >13 g/dL in women and men, respectively). Multivariate logistic regression analysis adjusting for patients' demographics, symptomatic status, comorbidities (diabetes, hypertension, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease), and preoperative medications as well as for aneurysm diameter, intraoperative blood loss, and concomitant procedures was performed.
Results: A total of 34,397 patients were included. Of those, 28.5% had mild anemia and 4.3% had severe anemia. In both OAR (n ¼ 6112) and EVAR (n ¼ 28,285), patients with severe anemia had significantly higher rates of mortality, myocardial infarction, MACE, renal and respiratory complications, and reoperation compared with patients with mild or no anemia. They also had longer operative times as well as intensive care unit and hospital stay (Table) . In addition, EVAR patients with severe anemia also had higher rates of acute congestive heart failure, dysrhythmia, and bowel and leg ischemia compared with patients with mild or no anemia. On multivariate analysis, severe anemia in patients undergoing OAR was associated with 80% higher odds of in-hospital MACE (odds ratio [OR], 1.83; 95% confidence interval [CI], 1.32-2.53; P < .001) and almost double the odds of 30-day mortality (OR, 1.91; 95% CI, 1.10-3.29; P ¼ .02). In EVAR, severe anemia was associated with double the risk of MACE (OR, 1.98; 95% CI, 1.43-2.74) and almost threefold the risk of 30-day mortality (OR, 2.92; 95% CI, 1.86-4.58; P < .001), whereas mild anemia increased the odds of MACE by 40% (OR, 1.37; 95% CI, 1.09-1.73) and 30-day mortality by 56% (OR, 1.56; 95% CI, 1.12-2.15). Interestingly, preoperative blood transfusion in mildly anemic patients undergoing EVAR was associated with 2.3 times the odds of MACE (OR, 2.3; 95% CI, 1.39-3.75; P < .01).
Conclusions: Severe anemia is an independent predictor of MACE and 30-day mortality after AAA repair. Blood transfusion for mild anemia before EVAR significantly increases adverse cardiac events. Thus, medical management of anemia in these patients might be a better option than transfusion. These findings highlight the need to incorporate anemia into the preoperative risk assessment of patients undergoing AAA repair and to identify a safe hemoglobin threshold to transfuse patients. BMI, Body mass index; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.
Background: In 2002, the Committee for Standardized Reporting Practices in Vascular Surgery of the Society for Vascular Surgery/American Association for Vascular Surgery proposed an anatomic severity grade score to categorize and to define anatomic factors as they relate to infrarenal abdominal aorta aneurysms (AAAs).
1 The original purpose of this score was to quantitatively assess anatomic complexity of the aorta before undertaking a repair. Our group previously reported that aortic anatomic complexity is a marker of atherosclerotic risk and resource utilization at the time of repair.
2,3 However, it remains unclear whether individual components to this scoredspecifically the aortic and iliac calcium burdend independently contribute to midterm survival after AAA repair. The purpose of this study was to analyze and to validate an aortic and iliac artery calcium scoring system that can predict midterm mortality after AAA repair. These data have direct implications for the population management-based treatment of aortic aneurysmal disease.
Methods: Patients with complete 5-year records who underwent open and endovascular infrarenal AAA repairs between July 2007 and May 2012 at the University of Rochester Medical Center were retrospectively identified using Current Procedural Terminology (American Medical Association, Chicago, Ill) codes 34800, 34802, 34803, 34804, and 34805. To avoid potential interference from perioperative mortality, those who died within 30 days of surgery were not included. Degree of vessel calcification was obtained from preoperative computed tomography scans no more than 6 months before surgery, calculated manually using three-dimensional reconstruction software (Philips Intellispace Portal; Koninklijke Philips Electronic NV, Andover, Mass) by two blinded reviewers. Calcium score (CS) was defined using the anatomic severity grade scoring system for its basis. 
